Next Article in Journal
Correction: Quinn et al. GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Escherichia coli Infection. Vaccines 2023, 11, 175
Next Article in Special Issue
Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD
Previous Article in Journal
Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Previous Article in Special Issue
Neurological Disorders following COVID-19 Vaccination
 
 
Article

Article Versions Notes

Vaccines 2023, 11(9), 1413; https://doi.org/10.3390/vaccines11091413
Action Date Notes Link
article xml file uploaded 24 August 2023 11:00 CEST Original file -
article xml uploaded. 24 August 2023 11:00 CEST Update https://www.mdpi.com/2076-393X/11/9/1413/xml
article pdf uploaded. 24 August 2023 11:00 CEST Version of Record https://www.mdpi.com/2076-393X/11/9/1413/pdf
article html file updated 24 August 2023 11:02 CEST Original file https://www.mdpi.com/2076-393X/11/9/1413/html
Back to TopTop